CRM, SPGI and INTU face execution challenges, while AI adoption, recurring revenues and product expansion shape their outlooks alongside micro-cap stocks KEQU and KTCC.
KEQU's fiscal Q1 results reflect weaker sales and LPG volumes, partly offset by stronger international profitability and cost control.
Kewaunee Scientific (KEQU) reported late Wednesday a fiscal Q1 earnings of $0.58 per diluted share,
Kewaunee Scientific (NASDAQ:KEQU) reported record revenue and outlined continued investments in product development, manufacturing capacity, international expansion and potential acquisitions during its 2026 annual meeting of stockholders. President and Chief Executive Officer Thomas D. Hull III sa
This is the newest page. Registered accounts read further back.